Skip to main content
. Author manuscript; available in PMC: 2018 Feb 15.
Published in final edited form as: Int J Cancer. 2016 Nov 18;140(4):825–832. doi: 10.1002/ijc.30512

Table 3.

Associations between breast cancer susceptibility loci and TDLU counts by menopausal status (SNPs with P<0.05) among women in the Komen Tissue Bank and BREAST Stamp Project.

SNP Chr Locus Premenopausal*
Postmenopausal*
P-heterogeneity**
RR 95% CI P-trend RR 95% CI P-trend
rs616488 1 PEX14 1.19 (1.01,1.41) 0.040 1.10 (0.81,1.50) 0.548 0.617
rs6678914 1 LGR6 0.87 (0.75,1.02) 0.094 1.28 (0.95,1.71) 0.101 0.027
rs6828523 4 ADAM29 1.33 (1.07,1.66) 0.011 0.74 (0.45,1.22) 0.236 0.036
rs11242675 6 FOXQ1 1.18 (1.03,1.35) 0.020 1.05 (0.79,1.38) 0.749 0.363
rs1011970 9 CDKN2A/B 0.94 (0.75,1.18) 0.617 1.43 (1.03,1.98) 0.031 0.032
rs11199914 10 10q26.12 1.04 (0.89,1.21) 0.633 0.71 (0.52,0.98) 0.036 0.037
rs3817198 11 LSP1 0.83 (0.71,0.97) 0.022 1.08 (0.76,1.52) 0.669 0.165
rs1292011 12 TBX3 0.93 (0.80,1.09) 0.381 0.74 (0.55,0.99) 0.044 0.164
rs6001930 22 MKL1 1.32 (1.08,1.61) 0.006 0.93 (0.53,1.63) 0.808 0.267

TDLU: Terminal duct lobular unit; SNP: Single nucleotide polymorphism; Chr: Chromosome; RR: Risk ratio; CI: Confidence interval.

*

Based on a multivariable Poisson regression model with robust variance adjusted for study and age (in categories: <30, 30-39, 40-49, 50-59, ≥60) and an offset variable accounting for the tissue area on the slide (in log scale). SNPs were modeled using additive coding for the number of breast cancer risk alleles (0, 1, 2).

**

P-heterogeneity was computed as the P-value associated with the interaction term between menopause and the corresponding SNP